1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Stage III Vulvar Cancer: new trials by email Literature Review of Stage III Vulvar Cancer trials Research Report on Stage III Vulvar Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu recombinant interleukin-12, ABI-007/carboplatin/trastuzumab - Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 15 | 1999-08-01 | 2013-02-28 |
Adenocarcinoma, Follicular (1) · Adrenocortical Carcinoma (1) · Anus Neoplasms (1) · Appendiceal Neoplasms (1) · Bile Duct Neoplasms (1) · Breast Neoplasms (1) · Breast Neoplasms, Male (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Islet Cell (1) · Carcinoma, Medullary (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Ovarian Epithelial (1) · Carcinoma, Renal Cell (1) · Colonic Neoplasms (1) · Endometrial Neoplasms (1)
Adenocarcinoma (1) · Adenocarcinoma, Papillary (1) · Adenoma (1) · Adenoma, Islet Cell (1) · Adnexal Diseases (1) · Adrenal Cortex Diseases (1) · Adrenal Cortex Neoplasms (1) · Adrenal Gland Diseases (1) · Adrenal Gland Neoplasms (1) · Anus Diseases (1) · Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Biliary Tract Neoplasms (1) · Breast Diseases (1) · Bronchial Neoplasms (1)
Interleukin-12 (1) · Interleukin-12 Subunit p35 (1) · Trastuzumab (1)
National Cancer Institute (NCI) (1)
United States (1)
William Carson (1)
U01CA076576 (1)